AI designed
EXOSOMES
Exosomes are nature's delivery vector. We turn them into programmable gene therapy with an autonomous agent stack. EXO-1, our first vector, ships today. EXO-2 next-gen is coming.
NATURE'S DELIVERY VECTOR
Every cell already ships instructions to other cells — packaged in exosomes. They cross barriers synthetic particles can't, slip past the immune system, and home to tissue by surface chemistry. Where LNPs pile up in the liver, exosomes go where you point them. We start with a vector evolution already perfected — then use AI to make it programmable.
- ·Biological
- ·Low immunogenicity
- ·Crosses the blood–brain barrier
- ·Tunable tropism
- ·Synthetic
- ·Liver-biased
- ·Highly immunogenic
- ·What we engineer past
THE AUTONOMOUS LAB FOR
EXOSOME DISCOVERY
Exosomes are nature's vector. Our agents turn them into an engineered product — optimizing four layers in a closed loop, learning from every batch.
Design → Build → Test → Learn. Autonomous. Tightening every round.
The first vector,
ready to deliver.
EXO-1, our first deployable vector: engineered exosomes in an intranasal formulation. Nature's nanocarrier — isolated, loaded, and routed across the nasal mucosa. The proof the platform works, made real.
- Intranasal route
- Exosome carrier
- Low immunogenicity
- RNA / protein cargo
- Tunable tropism
Back the agent stack.
$EXO funds the agent fleet, the vectors they optimize, and the IP — community-owned, onchain. Drop your email; we'll ping you the moment the launch is live.